A Retrospective Study of COVID-19 Treatments
NCT04949230 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2024-02-29
Summary
Surveys administered to subjects who have recovered from COVID-19 to assess how effective their treatment was.
Conditions
- Covid19
- COVID-19 Pneumonia
- COVID-19 Respiratory Infection
- COVID-19 Acute Bronchitis
- COVID-19 Acute Respiratory Distress Syndrome
- COVID-19 Lower Respiratory Infection
- SARS-CoV2 Infection
- SARS-CoV-2 Acute Respiratory Disease
Interventions
- OTHER
-
No Intervention Used
There is no intervention in this study
Sponsors & Collaborators
-
ProgenaBiome
lead OTHER
Principal Investigators
-
Sabine Hazan, MD · ProgenaBiome
Eligibility
- Min Age
- 18 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-19
- Primary Completion
- 2024-02-15
- Completion
- 2024-02-15
Countries
- United States
Study Locations
More Related Trials
-
Use of Compromised Lung Volume in Monitoring Usage of Steroid Therapy on Severe COVID-19
NCT04953247 ·Status: COMPLETED
-
Prophylaxis and Treatment of COVID-19
NCT04844541 ·Status: COMPLETED
-
An Observational Study of Patients With Coronavirus Disease 2019
NCT04331886 ·Status: COMPLETED
-
Virological and Immunological Monitoring in Patients (suspected Of/confirmed With) COVID-19
NCT04904692 ·Status: ACTIVE_NOT_RECRUITING
-
Ozone Therapy and Coronavirus Disease of 2019 (COVID-19) Pneumonia
NCT04444531 ·Status: COMPLETED
-
Efficacy and Safety of Corticosteroids in COVID-19
NCT04273321 ·Status: COMPLETED ·Phase: NA
-
Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections
NCT04357938 ·Status: COMPLETED
-
Performance Assessment of SARS-CoV-2 Detection Breath Biopsy - SARS-CoV-2 Study
NCT04508556 ·Status: COMPLETED
-
Pilot Test of COVID-19 Related Clinical Outcome Assessment Methodology and Qualitative Evidence of Content Validity
NCT05207293 ·Status: COMPLETED
-
Microbiome Analysis of Skin and Airway Samples and Effect of Face Masks
NCT04894422 ·Status: UNKNOWN
-
Cytokine and Eicosanoid Mediators in Coronavirus Disease 2019 (COVID-19)
NCT04452942 ·Status: UNKNOWN
-
A COVID-19 Symptom, Exposure and Immune Response Registry
NCT04348942 ·Status: COMPLETED
-
Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)
NCT04952337 ·Status: UNKNOWN
-
Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19
NCT04912895 ·Status: COMPLETED ·Phase: NA
-
Steroid and Anticoagulant Therapy in covid19
NCT05021588 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia
NCT04359511 ·Status: WITHDRAWN ·Phase: PHASE3
-
An Observational, Ambispective Cohort Study of Azvudine in the Treatment of Patients With COVID-19 Pneumonia
NCT05621993 ·Status: UNKNOWN
-
A Study of ORTD-1 in Patients Hospitalized With COVID-19 Related Pneumonia
NCT04708236 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia
NCT04263402 ·Status: UNKNOWN ·Phase: PHASE4
-
Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia
NCT04275388 ·Status: UNKNOWN
-
Observational, Prospective Clinical Study to Evaluate Biomarkers as Indicators of Acute Bacterial or Viral Infections
NCT01917461 ·Status: COMPLETED
-
Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19
NCT04581135 ·Status: COMPLETED
-
Biomarkers for Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia
NCT04619693 ·Status: TERMINATED
-
Quantifying Viral Load in Respiratory Particles That Are Generated by Children and Adults With COVID-19 Infection
NCT05195229 ·Status: UNKNOWN ·Phase: NA
-
Indirect Endovenous Systemic Ozone for New Coronavirus Disease (COVID19) in Non-intubated Patients
NCT04359303 ·Status: UNKNOWN ·Phase: PHASE3